InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Crouse Steven C.. Director active across 2 companies, notably BIO-TECHNE Corp. Aggregated, 8 reports have been logged. Activity tracked since 1 May 2026. The latest transaction was filed on 15 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Crouse Steven C. is a declarant linked to BIO-TECHNE Corp, where he is President - Diag & Spatial Bi, and to OmniAb, Inc., where he is Director. His 5 filings on record run from 2026-05-05 to 2026-06-18, and the transactions observed in this recent sample relate to option exercises, with published amounts of EUR 14588.68404867688 and EUR 9256.0259326732.